Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
MedPharm is a contract development and manufacturing organization (CDMO) focused on topical, transdermal, and transepithelial drug products, supporting formulation development, in vitro testing, and GMP manufacturing from early development through commercial supply. It serves pharmaceutical and biotechnology companies, with facilities in Guildford, UK, and Durham, North Carolina, USA.
2 investors
Meduloc develops minimally invasive intramedullary implants for internal fixation of small and long-bone fractures. Its products are intended for orthopedic surgeons treating fracture patients in the medical device field.
2 investors
Medytox is a South Korean biopharmaceutical company that develops and manufactures botulinum toxin products and hyaluronic acid dermal fillers. Founded in 2000, it operates domestic R&D centers and production plants in Korea along with subsidiaries and joint ventures in the US, Taiwan, Hong Kong, Thailand, and Japan.
2 investors
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
2 investors
Mereo BioPharma is a biopharmaceutical company that develops novel therapies for rare diseases with limited or no treatment options, focusing on lead programs in osteogenesis imperfecta (OI) and Alpha-1 Antitrypsin Deficiency-associated Lung Disease (AATD-LD). It operates a capital-efficient model, acquiring high-potential therapies from pharmaceutical and biotechnology companies and advancing them through clinical development in partnership with patient communities.
2 investors
Merida is a biotherapeutics company developing a new class of drugs designed to selectively and durably eliminate the pathogenic antibodies that drive autoimmune and allergic diseases. Its work spans discovery, drug development, and clinical operations aimed at treating patients with these conditions.
2 investors
Mestastop develops research platforms and assays to study cancer metastasis biology and support early diagnosis and drug development. The company serves oncology researchers and pharmaceutical companies developing metastasis-prevention therapies.
2 investors
Metaphore develops a platform that measures biological activity inside cells at scale to design antibody medicines with novel mechanisms of action. The company aims to create antibodies that activate pathways, modulate signaling, and engage multiple targets to treat complex diseases.
2 investors
MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.
2 investors
Metrion Biosciences provides ion channel screening and drug discovery services for pharmaceutical and biotech companies. The company specializes in preclinical contract research operations with over 100 years of combined team expertise in ion channel biology.
2 investors
Mewery is a foodtech venture developing cultivated meat with the stated aims of helping animals and the planet and changing how meat is produced and consumed. It positions itself around alternative/cultured meat technology.
2 investors
MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.
2 investors
MiAlgae uses whisky distillation by-products to grow microalgae rich in marine Omega 3s, offering a plant-based, low-carbon alternative to fish oil. The Omega 3 rich algae is dried for use in farmed fish feed and pet food.
2 investors
Prolific Earth Sciences develops microBIOMETER, an on-site soil health diagnostic test that measures microbial biomass and fungal-to-bacterial ratios to help growers and agricultural practitioners assess soil quality. The company serves regenerative agriculture and landscaping practitioners seeking rapid, affordable alternatives to costly laboratory testing.
2 investors
Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
2 investors
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups. The company operates at the clinical stage and is building manufacturing capacity for needle-free pharmaceuticals.
2 investors
miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.
2 investors
Mimetas provides microfluidic technology and services for 3D tissue culture research, offering pre-built tissue models, instrumentation, and platforms for pharmaceutical and safety testing applications.
2 investors
MIMOSA Diagnostics develops medical devices and technology to improve healthcare equity through diagnostic solutions. The company focuses on skin and wound healing diagnostics with a team led by experienced medical device engineers and healthcare professionals.
2 investors
Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology. The company operates in the digital health and diagnostics space.
2 investors
MindMaze develops neurotherapeutic solutions combining behavioral therapy, software, devices, and data to treat and manage neurological disease and support brain health and recovery. Its precision neurotherapeutic products are used by patients and caregivers in clinical centers worldwide.
2 investors
Mindpeak develops AI-powered diagnostic software for cancer pathology, translating complex tissue data into clinical insights to support treatment decisions. The company serves pathologists and clinical institutions working in cancer diagnostics and drug development.
2 investors
Discovers and develops microRNA-targeting therapies for areas of high unmet medical need.
2 investors
Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
2 investors